Advertisement

Alveolar Surfactant and Inflammatory Mediators

  • M. Hallman
Conference paper

Abstract

Alveolar surfactant is a lipid protein complex that prevents atelectasis, decreases work of breathing, and promotes uniform expansion of alveoli allowing efficient gas exchange. In addition, the surfactant protects the alveoli and the small airways against edema and mechanical trauma. Surfactant also contains components that are involved in defense against microbes and xenobiotics. According to present hypothesis non-clonal innate immunity — an ancient non-vertebrate defense system — is important in host defense particularly in transcellular spaces. This system has evolved to function in a natural state of infectious and inflammatory diseases. The present methods of intensive care have been developed in the absence of the knowledge of the function of the host defense system. It is conceivable that the new and effective invasive treatment practices “fool” the innate immunity to trigger an inappropriate response that becomes destructive rather than protective to the host.

Keywords

Adult Respiratory Distress Syndrome Surfactant System Surfactant Protein Keratinocyte Growth Factor Alveolar Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stahlman MT, Orth DN, Gray ME (1989) Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. Lab Invest 60: 539 - 547PubMedGoogle Scholar
  2. 2.
    Sundell HW, Gray ME, Serenius FS et al (1980) Effects of epidermal growth factor on lung maturation in fetal lambs. Am J Pathol 100: 707 - 726PubMedGoogle Scholar
  3. 3.
    Whitsett JA, Weaver TE, Lieberman MA et al (1987) Differential effects of epidermal growth factor and transforming growth factor-(3 on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung. J Biol Chem 262: 7908 - 7913PubMedGoogle Scholar
  4. 4.
    Goetzman BW, Read LC, Plopper CG et al (1994) Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. Pediatr Res 35: 30 - 36PubMedCrossRefGoogle Scholar
  5. 5.
    Klein JM, Nielsen HC (1995) Androgen regulation of epidermal growth factor receptor binding activity during fetal rabbit lung development. J Clin Invest 91: 425 - 431CrossRefGoogle Scholar
  6. 6.
    Sibilia M, Wagner EF (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234 - 238PubMedCrossRefGoogle Scholar
  7. 7.
    Roberts AB, Sporn MB (1992) Differential expression of the TGF- 3 isoforms in embryogenesis suggests specific roles in developing and adult tissues. Molec Reprod Devel 32: 91 - 98CrossRefGoogle Scholar
  8. 8.
    Kulkarni AB, Ward JM, Yaswen L et al (1995) Transforming growth factor-(3 1 null mice. An animal model for inflammatory disorders. Am J Pathol 146: 264-275PubMedGoogle Scholar
  9. 9.
    Bry K, Hallman M, Teramo K et al (1997) Granulocyte-macrophage colony-stimulating factor in amniotic fluid and in airway specimens of newborn infants. Pediatr Res 41: 105 - 109PubMedCrossRefGoogle Scholar
  10. 10.
    Huffman Reed JA, Rice WR, Zsengeller ZK et al (1997) GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice. Am J Physiol 273: L715 - L725Google Scholar
  11. 11.
    Uy CC, Bry K, Lappalainen U, Hallman M (1999) Granulocyte-macrophage colony-stimulating factor increases surfactant phospholipid in premature rabbits (in press)Google Scholar
  12. 12.
    Dranoff G, Crawford AD, Sadelain M et al (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713 - 716PubMedCrossRefGoogle Scholar
  13. 13.
    Ikegami M, Ueda T, Hull Wet al (1996) Surfactant metabolism in transgenic mice after granulocyte-macrophage colony-stimulating factor ablation. Am J Physiol 270: L650 - L658PubMedGoogle Scholar
  14. 14.
    Shannon JM, Gebb SA, Nielsen LD (1999) Induction of alveolar type II cell differentiation in embryonic tracheal epithelium in mesenchyme-free culture. Development 126: 1675 - 1688PubMedGoogle Scholar
  15. 15.
    Deterding RR, Havill AM, Yano T et al (1997) Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc Ass Amer Physicians 109: 254 - 268Google Scholar
  16. 16.
    Yano T, Deterding RR, Simonet WS et al (1996) Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol 15: 433 - 442PubMedGoogle Scholar
  17. 17.
    Buch C, Gallati H, Pohlandt F, Bartmann P (1994) Increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 0 in tracheal aspirates of newborns with pneumonia. Infection 22: 238 - 241CrossRefGoogle Scholar
  18. 18.
    Suter PM, Suter S, Girardin E et al (1992) High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Disease 145: 1016 - 1022CrossRefGoogle Scholar
  19. 19.
    Parsons PE, Moore FA, Moore EE et al (1992) Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 146: 694 - 700PubMedGoogle Scholar
  20. 20.
    Wispe JR, Clark JC, Warner BB et al (1990) Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 86: 1954 - 1960PubMedCrossRefGoogle Scholar
  21. 21.
    Bachurski CJ, Pryhuber GS, Glasser SW et al (1995) Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J Biol Chem 270: 19402 - 19407PubMedCrossRefGoogle Scholar
  22. 22.
    Miyazaki Y, Araki K, Vesin C et al (1995) Expression of a tumor necrosis factor-a transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 96: 250-259PubMedCrossRefGoogle Scholar
  23. 23.
    Ballard PL, Liley HG, Gonzales LW et al (1990) Interferon-y and synthesis of surfactant components by cultured human lung. Am J Respir Cell Mol Biol 2: 137 - 143PubMedGoogle Scholar
  24. 24.
    Dinarello CA (1991) Interleukin- I and interleukin-1 antagonism. Blood 77: 1627 - 52PubMedGoogle Scholar
  25. 25.
    Siler TM, Swierkosz JE, Hyers TM et al (1989) Immunoreactive IL-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res 15: 881 - 894PubMedCrossRefGoogle Scholar
  26. 26.
    Kotecha S, Wilson L, Wangoo A et al (1996) Increase in interleukin (IL)-la and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 40: 250 - 256PubMedCrossRefGoogle Scholar
  27. 27.
    Gomez R, Ghezzi F, Romero R et al (1995) Premature labor and intra-amniotic infection: Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 22: 281-342PubMedGoogle Scholar
  28. 28.
    Watterberg KL, Demers LM, Scott SM, Murphy S (1996) Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia developes. Pediatrics 97: 210 - 215PubMedGoogle Scholar
  29. 29.
    Bry K, Lappalainen U, Hallman M (1997) Intra-amniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 99: 2992 - 2999PubMedCrossRefGoogle Scholar
  30. 30.
    Bry K, Lappalainen U, Hallman M (1997) Maturational effects of IL-1 on fetal lungs are dependent on route of cytokine administration. Pediatr Res 41: 42Google Scholar
  31. 31.
    Emerson GA, Bry K, Hallman M et al (1997) Intra-amniotic interleukin-1 alpha treatment alters postnatal adaptation in premature lambs. Biol Neonate 72: 370 - 379PubMedCrossRefGoogle Scholar
  32. 32.
    Glumoff V, Väyrynen O, Kangas T, Hallman M (1999) Degree of lung maturity determines the direction of interleukin-1 induced effect on the expression of surfactant proteins. Am J Respir Cell Mol Biol (in press)Google Scholar
  33. 33.
    Leff JA, Baer JW, Bodman ME et al (1993) Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite mediated lung leak in rats. J Appl Physiol 266: 2 - 8Google Scholar
  34. 34.
    Repine JE (1994) Interleukin- 1-mediated acute lung injury and tolerance to oxidative injury. Environ Health Prospect 102[Suppl 101: 75 - 78Google Scholar
  35. 35.
    Väyrynen O, Glumoff V, Kangas T, Hallman M (1999) Endotoxin-induced changes in expression of surfactant proteins are dependent on the degree of lung maturity. Pediatr Res 45: 896CrossRefGoogle Scholar
  36. 36.
    Glumoff V, Väyrynen O, Kangas T, Hallman M (1999) Expression of surfactant proteins. Interaction between interleukin-1 (IL-1) and dexamethasone ( Dx ). Pediatr Res 45: 892Google Scholar
  37. 37.
    Aikio O, Vuopala K, Pokela M-L, Hallman M (1999) Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia. Pediatrics (in press)Google Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • M. Hallman

There are no affiliations available

Personalised recommendations